Related Experiment Video
Updated: Mar 28, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Identification of Gender-Specific Genetic Variants in Patients With Bicuspid Aortic Valve
Natasha Dargis1, Maxime Lamontagne1, Nathalie Gaudreault1
1Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Quebec City, Quebec, Canada.
Insights
Genetic variants in the EGFR gene are associated with bicuspid aortic valve (BAV), a common congenital heart defect. This study also suggests gender-specific genetic factors may influence BAV development.
Area of Science:
- Cardiovascular Genetics
- Congenital Heart Disease
- Genomics
Background:
- Bicuspid aortic valve (BAV) is the most common congenital heart defect, affecting males disproportionately.
- BAV often leads to serious valvular and aortic complications.
- The genetic underpinnings of BAV remain largely unknown.
Purpose of the Study:
- To identify genetic variants associated with BAV.
- To investigate potential gender-specific genetic influences on BAV development.
Main Methods:
- Sequencing of nine candidate genes in 48 BAV patients.
- Evaluation of variant pathogenicity using the Combined Annotation Dependent Depletion (CAD) framework.
- Genotyping of 89 variants in 323 BAV cases and 584 controls, with gender-stratified analyses.
Main Results:
- Identified novel and potentially pathogenic variants, but none showed association with BAV in the case-control cohort.
- Discovered a significant association between an intronic EGFR variant (rs17290301) and BAV.
- Revealed distinct genetic variants associated with BAV in men (EGFR, TEX26) and women (NOTCH1, TGFBR2, NKX2-5).
Conclusions:
- This study establishes the first association between EGFR genetic variants and BAV in humans.
- Findings support a role for gender-specific genetic polymorphisms in BAV pathogenesis.
- Further research into the genetic architecture of BAV is warranted.
Abstract:
Bicuspid aortic valve (BAV) is the most frequent congenital heart defect and has a male predominance of 3 to 1. A large proportion of patients develop valvular and aortic complications. Despite the high prevalence of BAV, its cause and genetic origins remain elusive. The goal of this study was to identify genetic variants associated with BAV. Nine genes previously associated with BAV (NOTCH1, AXIN1, EGFR, ENG, GATA5, NKX2-5, NOS3, PDIA2, and TGFBR2) were sequenced in 48 patients with BAV using the Ion Torrent Personal Genome Machine. Pathogenicity of genetic variants was evaluated with the Combined Annotation Dependent Depletion framework. A selection of 89 variants identified by sequencing or in previous BAV genetic studies was genotyped, and allele frequencies were compared in 323 patients with BAV confirmed at surgery and 584 controls. Analyses were also performed by gender. Nine novel and 19 potentially pathogenic variants were identified by next-generation sequencing and confirmed by Sanger sequencing, but they were not associated with BAV in the case-control population. A significant association was observed between an in silico-predicted benign EGFR intronic variant (rs17290301) and BAV. Analyses performed by gender revealed different variants associated with BAV in men (EGFR rs533525993 and TEX26 rs12857479) and women (NOTCH1 rs61751489, TGFBR2 rs1155705, and NKX2-5 rs2277923). In conclusion, these results constitute the first association between EGFR genetic variants and BAV in humans and support a possible role of gender-specific polymorphisms in the development of BAV.
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pedigree Analysis
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Mitral Stenosis II: Clinical features and Diagnostic Tests

